Loading
Latest filing published 18 Oct 2017 for The Canadian Bioceutical Corporation, €20k.
Donald Stott discloses dealings in The Canadian Bioceutical Corporation to SEDI. Over a trading history stretching from 17 March 2017 to 17 October 2017, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 18 October 2017 with an option exercise (€20k) in The Canadian Bioceutical Corporation. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations